HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 275 filers reported holding HAEMONETICS CORP in Q3 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $31,588,011,000 | -20.3% | 344,772 | 0.0% | 0.31% | +17.0% |
Q4 2019 | $39,614,303,000 | +73945.4% | 344,772 | -18.7% | 0.26% | -29.0% |
Q3 2019 | $53,500,000 | +4.8% | 424,133 | 0.0% | 0.37% | +6.3% |
Q2 2019 | $51,040,000 | +37.6% | 424,133 | 0.0% | 0.35% | +33.5% |
Q1 2019 | $37,103,000 | -12.6% | 424,133 | 0.0% | 0.26% | -26.7% |
Q4 2018 | $42,434,000 | -12.7% | 424,133 | 0.0% | 0.36% | +3.2% |
Q3 2018 | $48,597,000 | – | 424,133 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |